By Stewart Eisenhart, Emergo Group
New guidance from the US Food and Drug Administration explains how its clinical investigation requirements pertaining to human subject protection policies correspond to US federal policy on human subject protections enforced by the Department of Health and Human Services (HHS).
Get the full story here at the Emergo Group’s blog.
The opinions expressed in this blog post are the author’s only and do not necessarily reflect those of MassDevice.com or its employees.
The post FDA clarifies human subject requirements for clinical investigations appeared first on MassDevice.
from MassDevice https://ift.tt/2Poi7S5
Cap comentari:
Publica un comentari a l'entrada